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Abstract
We examined the potential gene × gene interactions and gene × smoking interactions in
rheumatoid arthritis (RA) using the candidate gene data sets provided by Genetic Analysis
Workshop 15 Problem 2. The multifactor dimensionality reduction (MDR) method was used to
test gene × gene interactions among candidate genes. The case-only sample was used to test gene
× smoking interactions. The best predictive model was the single-locus model with single-
nucleotide polymorphism (SNP) rs2476601 in gene PTPN22. However, no clear gene × gene
interaction was identified. Substantial departure from multiplicativity was observed between
smoking and SNPs in genes CTLA4, PADI4, MIF, and SNPs on chromosome 5 and one haplotype of
PTPN22. The strongest evidence of association was identified between the PTPN22 gene and RA
status, which was consistently detected in single SNP association, gene × gene interaction and gene
× smoking interaction analyses.
Background
Rheumatoid arthritis (RA) is a complex autoimmune dis-
ease. The etiology of the disease is not clearly understood.
Risk factors of RA include genetic factors, race (Native
American), female gender, obesity, old age, and smoking
[1,2]. However, like most complex diseases, few studies of
gene × gene interaction and gene × environmental interac-
tion have been performed because a large sample size is
required to identify such effects in traditional statistical
paradigms. Logistic regression is commonly used in
detecting interactive effects between genes or environ-
mental factors in epidemiologic studies. However, the
parameters cannot be accurately estimated when there are
many independent variables while the sample size is not
large enough [3]. Recently, Ritchie et al. [4] introduced a
multifactor dimensionality reduction (MDR) method for
identifying gene × gene interaction or gene × environmen-
tal interaction to overcome this limitation of traditional
logistic regression [3-5]. This approach enumerates all
possible combinations of genotype or environmental fac-
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tors associated with high risk and low risk of disease, and
it may enable us to find interactions between genes in the
absence of main effects [3-5].
To detect potential epistasis in RA, we evaluated 1) disease
associations using single SNPs (single-nucleotide poly-
morphisms) from 15 candidate genes and haplotypes of
the PTPN22 gene, 2) gene × gene interactions among the
candidate genes using the MDR method and logistic
regression, and 3) gene × environmental (smoking) inter-
actions using a case-only study design.
Methods
Materials
The data sets for the candidate gene studies of RA were
provided by Genetic Analysis Workshop 15 (GAW15)
Problem 2. There were two case-control data sets. The first
one included 855 unrelated controls and 839 cases, as
well as genotype data on 20 SNPs from 15 candidate
genes, which were selected from previously published
associations with RA or other autoimmune disorders by
Plenge et al. [6]. The second data set included 1519 unre-
lated controls and 1393 cases, and genotype data on 14
SNPs from the PTPN22 gene. Additional phenotype data,
including smoking history, age of onset, sex, and body
mass index, were available for cases only in both data sets.
There were 408 and 720 affected sibling pairs among cases
in the two data sets, respectively.
Statistical analysis
Single SNP and haplotype (PTPN22  only) associations
with disease status were first evaluated. To account for the
dependency among family members, the generalized esti-
mating equations methods (GEE1) [7] as implemented in
the GENMOD procedure of SAS 9.0 was utilized in the
association analysis by using family as the cluster factor,
i.e., members from the same family were assumed to be
correlated and those from different families were assumed
to be independent. The haplotype block structure of
PTPN22 was evaluated by Haploview [8]. Individual hap-
lotypes were reconstructed using the PHASE 2.0 by assign-
ing each haplotype with maximum probability [9].
Seventy-four percent of haplotype assignments had prob-
abilities of 100% and 93% had probabilities of 80% or
better. Individuals whose haplotype assignment had
probability below 80% were excluded from subsequent
analysis. Association analysis was carried out for each
common haplotype in turn. For each haplotype, a domi-
nant model was assumed, i.e., carriers of the particular
haplotype versus non-carriers were compared for their RA
status.
To test gene × gene interactions, MDR was used to deter-
mine the genetic model that could most successfully pre-
dict the disease status or phenotype from several loci. SNP
rs2240340 on the PADI4 gene was excluded from analysis
due to its large amount of missing data. One thousand
three hundred and thirty case-control samples with com-
pleted marker data on 19 SNPs from 14 candidate genes
were utilized in the MDR analysis. Cross-validation (CV)
consistency and balanced accuracy estimates were calcu-
lated for each combination of a pool of genetic polymor-
phisms. The model with the highest accuracy and
maximal CV was considered to be the best [5]. We deter-
mined statistical significance by comparing the accuracy
of the observed data with the distribution of accuracy
under the null hypothesis of no associations derived
empirically from 1000 replicates of permutations [10].
The null hypothesis was rejected when the p-value derived
from the permutation test was 0.05 or less. As a follow-up,
logistic regression analysis was conducted if there was sug-
gestive interaction.
We also examined the interaction between SNPs and
smoking history in RA cases. The logistic function in the
GENMOD procedure was used to quantify departure from
multiplicativity. Odds ratios and 95% CIs were estimated.
To adjust for multiple tests, empirical p-values were
obtained from 1000 permutations. For the PTPN22 gene,
interaction effects between PTPN22  haplotypes and
smoking among cases were evaluated for RA status.
Results
1. Single SNP and PTPN22 haplotype association
Table 1 lists the association analysis results between dis-
ease and individual markers. One SNP from each of the
five genes, HAVCRI, CTLA4, SUMO4, MAP3K7IP2, and
PTPN22, were found significantly associated with RA.
Five common haplotypes of the PTPN22 with frequency
>10% were constructed. Of the two haplotypes with sig-
nificant associations with RA, one was a risk haplotype
(11222221122221; 1: minor allele, 2: major allele; fre-
quency: 11.6%), with a higher carrier frequency in cases
than in controls (30.0% vs. 14.9%, p < 0.0001); whereas
the other was protective (22122222222222; frequency:
10.9%), with a lower carrier frequency in cases than in
controls (16.4% vs. 24.7%, p < 0.0001).
2. Gene × gene interaction
Table 2 lists the results from MDR. The one-locus model
with SNP rs2476601 on gene PTPN22 had a maximum
test accuracy (p = 0.004) and a maximum CV consistency
of 10 out of 10, indicating that this was the best model.
The second-best model was a two-locus model consisting
of rs1248696 on the DLG5  gene and rs2476601 on
PTPN22 (p = 0.013). The combination of rs1248696_22
and rs2476601_22 was associated with being in the low-
risk group when compared to others (OR = 0.46, 95%CI:
0.36, 0.60). However, we could not confirm the interac-BMC Proceedings 2007, 1(Suppl 1):S17 http://www.biomedcentral.com/1753-6561/1/S1/S17
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tive effect between these two markers in the follow-up
logistic regression analysis under the GEE model. No bet-
ter models were identified for three and/or more locus
models.
3. Gene × smoking interaction
Two categories of environmental exposure, ever smoked
and current smoking, were used to test for gene × environ-
mental interactions. No significant departure from multi-
plicativity was observed between current smoking and
markers. Interactive effects with ever smoking were found
in the primary analysis for five SNPs, including CT60 on
the CTLA4 gene, rs2240340 on PADI4, IGR3084ms1 and
IGR3138ms1 on chromosome 5, and rs755622 on the
MIF gene. The empirical p-values derived from the 1000
permutations were similar to the nominal ones (Table 3).
One of the common haplotype of PTPN22
(22222222211221, frequency: 18%) was found to inter-
act with ever smoking at borderline significant level (OR
= 0.78, 95%CI: 0.60–1.01, p = 0.06); however, the risk
and the protective haplotypes that were identified previ-
ously in the case-control sample did not show any depar-
ture from multiplicativity with smoking in the case-only
study.
Discussion
We explored gene × gene and gene × smoking interactions
using the candidate gene data set provided by GAW15.
The best predictive model for RA status is the single-locus
model containing rs2476601 on gene PTPN22. SNP
rs2476601 is a well known functional SNP that is associ-
ated with increased risk of RA. The best combination
model selected by MDR consisted of rs2476601 on
PTPN22 and rs1248696 on DLG5. However, the suscepti-
bility interaction was not confirmed in the following
logistic regression analysis. The possible reason for the
inconsistent results is that in MDR, we actually did not test
statistical interaction which was defined as 'deviation
from multiplicativity' as in logistic regression. The signifi-
Table 2: Multilocus interaction model for RA selected from MDR
Model Balanced accuracy CV consistency p-value
rs2476601 (PTPN22) 0.5747 10/10 0.004a
rs2476601 (PTPN22) rs1248696 (DLG5) 0.5705 8/10 0.013
rs2476601 (PTPN22) rs6149307 (HAVCRI) rs2243250 (IL4) 0.5534 7/10 0.09
rs2476601 (PTPN22) IGR2096ms1 (chr 5) rs237025 (SUMO4) rs2268277 (RUNX1) 0.5243 6/10 0.475
aBold text indicates p < 0.05.
Table 1: Association between SNPs and RA
Candidate gene SNP p-value (11 vs. 12 vs. 22) p-value (11/12 vs. 22)
HAVCRI 5509_5511delCAA 0.066 0.034a
HAVCRI rs6149307 0.189 0.068
CTLA4 CT60 0.016 0.005
CARD15 HugotSNP12ms3 --b 0.754
CARD15 HugotSNP8ms2 0.838 0.553
CARD15 Hugot_SNP13ms2 -- 0.695
Chr 5 IGR2096ms1 0.473 0.243
Chr 5 IGR3084ms1 0.819 0.713
Chr 5 IGR3138ms1 0.861 0.732
IL3 rs31480 0.618 0.384
SUMO4 rs237025 0.0003 <0.0001
MAP3K7IP2 rs577001 0.002 0.001
MIF rs755622 0.842 0.979
TNFRFF1b rs1061622 0.704 0.684
DLG5 rs1248696 0.269 0.129
SLC22A4 rs2073838 0.904 0.771
PADI4 rs2240340 0.574 0.330
IL4 rs2243250 0.311 0.147
RUNX1 rs2268277 0.55 0.583
PTPN22 rs2476601 <0.0001 <0.0001
Allele "1" is the putative susceptibility allele, and allele "2" is the non-susceptibility allele
aBold text indicates p < 0.05.
b--, Results are not available because there is no homozygote "11" in some groups.BMC Proceedings 2007, 1(Suppl 1):S17 http://www.biomedcentral.com/1753-6561/1/S1/S17
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cant results from MDR only implies that the combination
of the markers contributes to an increased or decreased
risk of disease and the effect between the markers could be
either multiplicative or deviation from multiplicative.
The case-only study has its particular advantage in testing
gene × environmental interaction and it requires smaller
sample size [11]. It allows us to test interactive effects in
the absence of the information from controls under the
assumption that the two risk factors are independently
distributed in the population at risk [10]. In GAW15 Prob-
lem 2, we used this design to identify a gene × smoking
interaction in RA because no smoking information was
available from controls. We assumed genetic polymor-
phism and smoking exposure are independent of one
another in controls. Substantial departure from multiplic-
ativity was observed between ever smoking and markers
from CTLA4, PADI4, MIF, and chromosome 5. Among
these markers, only SNP CT60 from gene CTLA4 showed
a main effect with RA in the single SNP analysis. One pos-
sible explanation for this phenomenon is that the exist-
ence of gene × smoking interactions could mask the true
genetic effect if we only test the marginal association,
especially when the gene status modifies the smoking
effect in the opposite directions in the total sample.
Another possible explanation is the difference in the
tested samples: only cases were used in the gene × smok-
ing interaction studies, while the single SNP association
was evaluated in the case-control sample.
PTPN22  has been reported to be associated with RA
[6,12]. In this study, we tested single gene association,
gene × gene interactions and gene × smoking interactions
using three different methods. In single SNP analysis,
PTPN22 showed the strongest association with RA status
(p < 0.0001). In the following gene × gene interaction
analyses by MDR, both the best single and the best com-
bined models included PTPN22 gene. Furthermore, hap-
lotype analysis using the second data set identified two
haplotypes of the PTPN22 associated with RA and more
importantly, there was a trend toward interaction between
this gene and smoking. Therefore, the consistent findings
here provide further evidence of the genetic involvement
of PTPN22 in the etiology of RA.
Conclusion
In conclusion, our analyses confirmed the role of genetic
and environmental factors in rheumatoid arthritis. Strong
evidence of association was identified for the PTPN22
gene, which was observed in all three analyses. Other
genes (HAVCRI,  CTLA4,  SUMO4,  MAP3K7IP2,  PAID4,
chromosome 5 locus, MIF) may also contribute to the
development of rheumatoid arthritis directly or within
the context of smoking.
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